Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SUTRO BIOPHARMA, INC.

(STRO)
  Report
Real-time Estimate Cboe BZX  -  01:44 2022-12-09 pm EST
7.550 USD   -4.19%
11/23Sutro Biopharma to Participate in Upcoming Investor Conferences
AQ
11/09Transcript : Sutro Biopharma, Inc. Presents at Credit Suisse 31st Annual Healthcare Conference, Nov-09-2022 08:35 AM
CI
11/09HC Wainwright Cuts Price Target on Sutro Biopharma to $20 From $30, Affirms Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SUTRO BIOPHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

01/10/2022 | 07:03am EST

Item 7.01. Regulation FD Disclosure.

On January 13, 2022, Sutro Biopharma, Inc. (the "Company") intends to present an updated corporate presentation at the 40th Annual J.P. Morgan Healthcare Conference held via virtual format. A copy of the corporate presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K. The corporate presentation will also be available on the Company's website in the Investors section at https://www.sutrobio.com/corporate-presentation/.

The information furnished with this report, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.




Exhibit   Description
Number

 99.1     Corporate Presentation
104         Cover Page Interactive Data File (embedded within the Inline XBRL document)



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about SUTRO BIOPHARMA, INC.
11/23Sutro Biopharma to Participate in Upcoming Investor Conferences
AQ
11/09Transcript : Sutro Biopharma, Inc. Presents at Credit Suisse 31st Annual Heal..
CI
11/09HC Wainwright Cuts Price Target on Sutro Biopharma to $20 From $30, Affirms Buy Rating
MT
11/08Earnings Flash (STRO) SUTRO BIOPHARMA Reports Q3 Revenue $25.1M
MT
11/08SUTRO BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
11/08Sutro Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months En..
CI
11/08Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and S..
AQ
11/03Sutro Biopharma Announces Oral Presentation at the 64th American Society of Hematology ..
AQ
11/02Sutro Biopharma to Participate in Upcoming Investor Conferences
AQ
10/24Sutro Biopharma, Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
More news
Analyst Recommendations on SUTRO BIOPHARMA, INC.
More recommendations